Introduction {#sec1-1}
============

Malaria continues to be a major health problem particularly for India and is spread over 35 states and union territories. The hilly regions of Northeast India are endemic for malaria. The eight states in this region record about 0.07-0.1 million (*Plasmodium falciparum*) malaria cases annually accounting for 12% of total reported cases in India.\[[@ref1]\] Assam itself accounts for 31.94% of the total reported *P. falciparum* cases from Northeastern region. The problem is compounded by P falciparum resistance. In India, resistance of *P. falciparum* to chloroquine (CQ), the cheapest and the most widely used drug was first reported in the year 1973 from Karbi-Anglong district and during 1974 in Nagaon district of Assam state.\[[@ref2][@ref3][@ref4][@ref5]\] India introduced sulphadoxine-pyrimethamine (SP) combination in 1982 as a second line of treatment.\[[@ref2]\] The antifolate drug pyrimethamine acts on the *P. falciparum* dihydrofolate reductase (*Pfdhfr*) enzyme and therefore inhibits the folate biosynthesis pathway of the parasite.\[[@ref6][@ref7]\] Sulfonamides act on parasite enzyme *P. falciparum* dihydropteroate synthetase (*Pfdhps*) which is responsible for folate metabolism.\[[@ref8][@ref9]\] Resistance is mediated by certain point mutations in *Pfdhfr and Pfdhps* which reduce its capacity to bind to this drug, resulting in the emergence of resistant parasite strains.\[[@ref6][@ref10][@ref11]\] *P. falciparum dhfr* mutations N51I, C59R, S108N, and I164L and *dhps* mutations S436A,A437G, K540E, A581G, and A613S/T give rise to sulfadoxine and pyrimethamine resistance (SPR).\[[@ref10]\] These mutations occur in a stepwise manner and the parasite bearing a higher number of *dhfr-dhps* mutations shows a higher level of SPR.\[[@ref12][@ref13]\] Resistance to SP has been reported in many countries.\[[@ref14][@ref15][@ref16][@ref17][@ref18]\] Few studies have evaluated the prevalence of mutations in *Pfdhfr and Pfdhps* genes associated with SPR among the *P. falciparum* field isolates in Assam. However, the information is limited. Hence the present study was undertaken.

Materials and Methods {#sec1-2}
=====================

Ethics {#sec2-1}
------

The study protocol was approved by the Ethics committee of the Regional malaria research center, Indian Council of Medical Research and written, informed consent was taken from all participants or their guardians. Assent was taken from children over the age of 7 years.

Study period {#sec2-2}
------------

The study was carried out during period from January 2012 to December 2013 through household visits as well as samples collected from patients with fever who were attending malaria clinics/Primary Health Centre (PHC) in malaria endemic areas of Assam.

Study area {#sec2-3}
----------

Assam state (89° *42′ E to 96° E* longitude *and 24° 8′ N to 28° 2′ N* latitude) which included Tinsukia, Sonitpur, Sivasagar, NC Hills, Lakhimpur, Karbi Anglong, Jorhat, Golaghat, Dibrugarh and Chirang districts.

Selection criteria {#sec2-4}
------------------

Patients with microscopic confirmed *P. falciparum* mono infection were eligible for enrolment irrespective of age, sex and disease severity. The patients who took antibiotics were excluded from the study. Clinical history was recorded for each subject. A brief epidemiological and demographical history was also collected from each participant using a structured questionnaire.

Patients and samples {#sec2-5}
--------------------

Two milliliter intravenous samples were collected from 281 individuals (aged from range 1.6 to 70 years) with fever/suspected with malaria infection/asymptomatic patients having history of malaria. Among 281 collected samples, 218 patients showed symptoms of malaria and the remaining 63 individuals were asymptomatic.

Microscopic examination {#sec2-6}
-----------------------

Thick and thin blood smears were prepared for all blood samples and stained with 10% Giemsa stain and examined under light microscopy. Samples were considered negative when no parasite was detected after examining 100X microscopic fields. Further Polymerase chain reaction was done in microscopic positive malaria *P. falciparum* samples for authentication. Number of parasites/μl of blood (thick/thin film) was calculated by number of observed asexual parasites × total WBC/RBC count per μl against 200 WBC in 100 microscopic fields/total nos. of RBC screened in 25 microscopic fields.

Detection of malaria parasite by PCR {#sec2-7}
------------------------------------

DNA extraction was done from 200 μl of whole blood samples using the QIAamp DNA Mini spin columns kit (Millipore Corporation). The extracted DNA was thereafter amplified by the PCR using a set of primers as described by Snounou *et al*. 1996.\[[@ref19]\] The amplified product was detected by electrophoresis on 1.5% agarose gel containing ethidium bromide and visualized on an ultraviolet transillumination. The Gel photographs were taken and specific amplified bands at 205 bp were observed.

Amplification of dhfr and dhps genes {#sec2-8}
------------------------------------

A nested PCR method was used in all samples. 5 μl of purified DNA were added to a final reaction volume of 50 μl to amplify a 648 base pair (bp) portion of the *dhfr* gene \[[Figure 1](#F1){ref-type="fig"}\] by using specific set of primers.\[[@ref20]\] Similarly, a 710 bp portion of the *dhps* gene \[[Figure 1](#F1){ref-type="fig"}\] was amplified by the use of specific primers.\[[@ref20]\] All the amplification was performed in a Thermal cycler (Gene Amp^®^ PCR System 9700 and Veriti, Applied Biosystems, Foster City, CA, USA). The amplified products were visualized by electrophoresis under UV transillumination. The amplified products were further purified with the QIAquick PCR purification kit (QIAGEN) before sequencing and sequenced commercially (Macrogen Inc. Seoul, Korea through Anshul Biotechnologies, Hyderabad, India). Sequencing was performed on an automated sequencer using standard protocols.

![Amplification of 648 bp portion of the ***dhfr*** gene and 710 bp portion of the ***dhps*** gene](JPGM-61-9-g001){#F1}

Statistical analysis {#sec2-9}
--------------------

The Statistical Package for Social Science (SPSS) version 16 was used. Continuous data were expressed as mean and standard deviation. Categorical data were expressed as percentages. The sequencing products were further edited in Bio-edit software. Single nucleotide polymorphisms of the concerned genes were detected through bioinformatics software DnaSP version v. 5.10.01.

Results {#sec1-3}
=======

Demographics {#sec2-10}
------------

A total of 281 blood samples (age range 1.6-70 years) were collected for microscopic examination, of which 37.72% (106/281) samples were positive for *P. falciparum*. Two of the 281 samples were positive for *P. vivax* and 2.49% (7/281) had mixed infection (*P. falciparum* + *P. vivax*). All the age groups and both the sexes were found affected with malarial infection. The largest numbers of *P. falciparum* cases were reported from Karbi Anglong district of Assam with a high proportion of infectivity \[Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}\]. A^+^ and B^+^ blood groups were more susceptible to malaria *P. falciparum* infection. It was seen that 38/63 (60.32%) of the total asymptomatic cases were *P. falciparum* positive whereas 68/218 (31.19%) of the symptomatic cases showed malarial *P. falciparum* infectivity. The mean parasite count was 4.35% (3.206; range 0.2% -15%).

###### 

District wise suspected/confirmed malaria *P. falciparum* (*Pf*)-positive cases in Assam

  District        Nos. of suspected malaria cases   Nos. of malaria *Pf*-positive cases
  --------------- --------------------------------- -------------------------------------
  Tinsukia        35                                11
  Sonitpur        7                                 0
  Sivasagar       33                                11
  NC Hills        15                                13
  Lakhimpur       25                                11
  Karbi Anglong   29                                26
  Jorhat          30                                9
  Golaghat        8                                 7
  Dibrugarh       86                                7
  Chirang         13                                11
  Total           281                               106

###### 

Demographic characteristics among suspected/confirmed malaria *P. falciparum* (*Pf*)-positive cases in Assam

  Age groups (in year)   Nos. of suspected malaria cases   Nos. of malaria *Pf*-positive cases
  ---------------------- --------------------------------- -------------------------------------
  1 to 10                53                                33
  11 to 20               67                                17
  21 to 30               63                                28
  31 to 40               49                                14
  41 to 50               30                                8
  51 above               19                                6
  Male                   156                               54
  Female                 125                               52
  Total                  281                               106

Mutation analysis and haplotype diversity {#sec2-11}
-----------------------------------------

A total of 106 (one hundred and six) *P. falciparum*-infected blood samples were studied for mutation analysis of *P. falciparum* dhfr and *P. falciparum* dhps genotypes among the isolates in different malaria endemic areas of Assam. Analysis was finally possible for 100 (one hundred) amplified products independently for both the genes. The *Pfdhfr* gene analysis revealed the existence of three haplotypes: Two associated with drug-resistance profile (ANRNI and AIRNI) and the ANCSI associated with SP sensitivity \[[Table 3](#T3){ref-type="table"}\]. Haplotype ANRNI is a double mutant (C59R+S108N) which has moderate levels of resistance to pyrimethamine while haplotype AIRNI is a triple mutant (N51I+C59R+S108N) having a higher level of resistance. The wild-type ANCSI was present in only 8% (8/100) of the isolates, whereas double-mutation ANRNI haplotype was prevalent in 90% (90/100) of analyzed samples and the triple mutant AIRNI was the least common and was recorded in only 2% (2/100) of *P. falciparum* isolates. The prevalence of C59R and S108N mutation in the *dhfr* sequence among the isolates is indicative of the key point mutation. Any other mutation should be associated with them linked with treatment failure. Mutation analysis at nucleotide level showed that at nucleotide position 152, A-T mutation (N51I), at nucleotide position 175,T-C (C59R) and at nucleotide position 323,G-A mutation (S108N) leads to the occurrence of ANRNI and AIRNI haplotype.

###### 

Locality wise circulation of *dhfr* genotypes of *P. falciparum* isolates in Assam linked with pyrimethamine resistance

  Districts                *P. falciparum dhfr* genotype (Nos. of isolates)        
  ------------------------ -------------------------------------------------- ---- -----
  Karbi Anglong (*n*=25)   2                                                  23   ---
  NC Hills (*n*=13)        1                                                  12   ---
  Chirang (*n*=9)          ---                                                7    2
  Golaghat (*n*=7)         1                                                  6    ---
  Dibrugarh (*n*=7)        1                                                  6    ---
  Sivasagar (*n*=11)       1                                                  10   ---
  Tinsukia (*n*=11)        1                                                  10   ---
  Lakhimpur (*n*=8)        0                                                  8    ---
  Jorhat (*n*=9)           1                                                  8    ---
  Total                    08                                                 90   2

The analysis of *dhps* mutation study revealed the presence of 7 haplotypes of which 6 were associated with drug-resistance profile (FAKAA, AGKAA, SGKGA, SGKAA, AGEAA and FGKAA) and the wild-type SAKAA haplotype \[[Table 4](#T4){ref-type="table"}\]. It was seen that the *P. falciparum dhps* haplotype FAKAA having a single mutation was found among 26%, wild-type haplotype in 7% isolates. Three different types of double mutant haplotypes were observed in the *P. falciparum* field isolates. Double-mutant haplotype AGKAA (S436A+A437G) was observed among 23%, SGKGA (A437G+A581G) among 8% and FGKAA (S436F+A437G) among 4% (4/100) isolates. The triple-mutant haplotype AGEAA (S436A+A437G+K540E) was seen among 26% isolates. At the nucleotide level it was seen that in nucleotide position 1306, T-G mutations (S436A), at 1307 position, C-T (S436F) mutation and at nucleotide site 1310, C-G (A437G) were associated with the occurrence of haplotype FAKAA, AGKAA, SGKAA and FGKAA. Likewise, at nucleotide location 1618, A-G (K540E) and mutation from C-G at nucleotide position 1742 (A581G) were accountable for the occurrence of other haplotypes of the *Pfdhps* gene associated with alternate level of sulphadoxine resistance.

###### 

District wise circulatory strain of *P. falciparum dhps* genotypes in Assam associated with sulphadoxine resistance

  District                 *P. falciparum dhps* genotype (Nos. of isolates)                                 
  ------------------------ -------------------------------------------------- ----- ----- ----- ----- ----- -----
  Karbi Anglong (*n*=22)   1                                                  11    4     6     ---   ---   ---
  NC Hills (*n*=11)        ---                                                8     1     2     ---   ---   ---
  Chirang (*n*=11)         ---                                                3     ---   ---   4     2     2
  Golaghat (*n*=7)         1                                                  ---   2     ---   ---   4     ---
  Dibrugarh (*n*=7)        1                                                  ---   2     ---   ---   4     ---
  Sivasagar (*n*=11)       1                                                  4     6     ---   ---   ---   ---
  Tinsukia (*n*=11)        1                                                  ---   4     ---   ---   6     ---
  Lakhimpur (*n*=11)       1                                                  ---   2     ---   ---   8     ---
  Jorhat (*n*=9)           1                                                  ---   2     ---   2     2     2
  Total                    7                                                  26    23    8     6     26    4

The *P. falciparum dhfr-dhps* two loci mutation analysis showed that there were a total of nine *dhfr-dhps* two loci genotypes present among the isolates \[[Table 5](#T5){ref-type="table"}\]. Triple mutant haplotypes for both (AIRNI-AGEAA) *dhfr-dhps* genes were observed only in Chirang district of Assam. ANRNI-FAKAA was found predominantly in Karbi Anglong, NC Hills, Chirang and Sivasagar district. ANRNI-AGKAA and ANRNI-AGEAA were the next common *dhfr-dhps* haplotypes. Only 5/94 (5.32%) of the total isolates had wild-type sequence for both enzymes while the rest 89/94 (94.68%) had mutations in either one gene or both genes (single to quadruple). It was seen that 88/94 (93.62%) isolates had polymorphisms in the sequences of both enzymes.

###### 

Distribution of *P. falciparum dhfr* and *dhps* two locus genotype in the isolates of Assam

  *P. falciparum dhfr* and dhps two locus genotype among the isolates of Assam                                                   
  ------------------------------------------------------------------------------ ----- ----- ----- ----- ----- ----- ----- ----- -----
  ANCSI-SAKAA                                                                    ---   1     1     1     ---   ---   1     1     ---
  ANRNI- SAKAA                                                                   ---   ---   ---   ---   ---   ---   ---   ---   1
  ANRNI-FAKAA                                                                    2     ---   ---   ---   ---   8     4     ---   11
  ANRNI-AGKAA                                                                    ---   2     2     2     2     1     6     4     4
  ANRNI-SGKGA                                                                    ---   ---   ---   ---   ---   2     ---   ---   5
  ANRNI-SGKAA                                                                    4     ---   ---   2     ---   ---   ---   ---   ---
  ANRNI-AGEAA                                                                    ---   4     4     2     6     ---   ---   6     ---
  ANRNI-FGKAA                                                                    1     ---   ---   2     ---   ---   ---   ---   ---
  AIRNI -AGEAA                                                                   2     ---   ---   ---   ---   ---   ---   ---   ---
                                                                                 9     7     7     9     8     11    11    11    21

Discussion {#sec1-4}
==========

Drug resistant *P. falciparum* parasite poses a great public health problem which hinders the control of malaria. Our study has shown the prevalence of SP resistance-associated mutation in the parasites, particularly *dhfr* and *dhps* genes in isolates collected from distinct geographical sites of Assam. There are three distinct haplotypes of the *dhfr* gene reported and all of these have also been reported elsewhere in Indian states and other countries \[[Table 6](#T6){ref-type="table"}\].\[[@ref16][@ref17][@ref21]\]

###### 

Regional and geographical distributions of point mutations in *dhfr* locus among *P. falciparum* isolates

  Nos. of mutation   A16V   N51I   C59R   S108N/T   I164L   Assam                                                                                              India                                       Other countries
  ------------------ ------ ------ ------ --------- ------- -------------------------------------------------------------------------------------------------- ------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1 (wild type)      A      N      C      S         I       Karbi Anglong, NC Hills, Golaghat, Dibrugarh, Sivasagar, Tinsukia and Jorhat                       Delhi, UP, Orissa and Assam (Kamrup)        Vietnam, Thailand, Kenya, Indonesia, Gabon, Papua New Guinea, Malawi, South Africa, Sudan, Cameroon, Tanzania, The Netherlands, Sierra Leone, Liberia and Brazil
  2                  A      N      R      N         I       Karbi Anglong, NC Hills, Chirang, Golaghat, Dibrugarh, Sivasagar, Tinsukia, Lakhimpur and Jorhat   Delhi, UP, Orissa, Assam (Kamrup) and Goa   Thailand, Kenya, Gabon, Malaysia, Indonesia, Mali, Iran, Malawi, South Africa, Cameroon, Vietnam, Oman, Afghanistan, Pakistan and Tanzania
  3                  A      I      R      N         I       Chirang                                                                                            Assam (Kamrup)                              Indochina, Thailand, Malaysia, Kenya, Gabon, Iran, Mali, Tanzania, Vietnam, Liberia, Malawi, South Africa and Peru

The ANRNI is found more commonly in Karbi Anglong, NC Hills, Chirang, Golaghat, Dibrugarh, Sivasagar, Tinsukia, Lakhimpur and Jorhat district of Assam and is in line with the resistance-associated *dhfr* haplotypes of Delhi, UP, Orissa, Goa and Kamrup district of Assam.\[[@ref16][@ref17][@ref21][@ref22]\] We found mutant allele AIRNI only in the isolates of Chirang district of Assam which is similar to the *P.falciparum dhfr* alleles reported earlier from Kamrup district.\[[@ref16][@ref17][@ref21][@ref22]\] The high prevalence of *Pfdhfr* 59R+ S108N mutation in our study indicates decreased susceptibility to pyrimethamine in different localities of Assam. Only 2% isolates in our study had the triple resistance-associated haplotype.

*Pfdhps* mutation analysis revealed predominance of triple mutant *Pfdhps* AGEAA (26%) haplotypes in Assam which also indicates a high grade of sulphadoxine resistance. To our knowledge, 6/7 genotypes reported here are also present in other parts of India \[[Table 7](#T7){ref-type="table"}\]. On the other hand several of the *dhfr-dhps* (AICNL, AIRTI, SGEAS, AGEGA, FGEGA) genotypes reported from other countries like Peru, Gabon, Thailand were not seen among our isolates.\[[@ref16][@ref17][@ref21]\] A novel *dhps* haplotype (FGKAA) was seen from Chirang and Jorhat district of Assam which has not been reported earlier from Indian *P. falciparum* field isolates but is reported from other countries \[[Table 7](#T7){ref-type="table"}\].

###### 

Regional and geographical distributions of point mutations in *dhps* locus among *P. falciparum* isolates

  Nos. of mutation   S436 F/A   A437/G   K 540E   A 581G   A 613   Assam                                                                                    India                                       Other countries
  ------------------ ---------- -------- -------- -------- ------- ---------------------------------------------------------------------------------------- ------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1 (wild type)      S          A        K        A        A       Karbi Anglong, Golaghat, Dibrugarh, Sivasagar, Tinsukia, Lakhimpur and Jorhat            Delhi, UP, Orissa, Assam (Kamrup)and Goa    Vietnam, Thailand, Afghanistan, Oman, Yemen, Sudan, Tanzania, Gambia, Papua New Guinea, Brazil, Pakistan Kenya, Indonesia, Gabon, Malaysia, Iran, Malawi and South Africa
  2                  F          A        K        A        A       Karbi Anglong, NC Hills, Chirang and Sivasagar                                           Delhi, UP, Orissa, Assam (Kamrup)and Goa    Kenya
  3                  A          G        K        A        A       Karbi Anglong, NC Hills, Chirang, Dibrugarh, Sivasagar, Tinsukia, Lakhimpur and Jorhat   Assam (Kamrup)                              Thailand, Vietnam and Gabon
  4                  S          G        K        G        A       Karbi Anglong and NC Hills                                                               Assam (Kamrup)                              Malaysia, Vietnam, Kenya, Tanzania, Thailand, Male and Venezuela
  5                  S          G        K        A        A       Chirang and Jorhat                                                                       Delhi, UP, Orissa, Assam (Kamrup) and Goa   Kenya, Mali, Tanzania, Brazil, Liberia, South Africa, Sudan, Venezuela, Indonesia, Malaysia, Gabon and Iran
  6                  A          G        E        A        A       Chirang, Dibrugarh, Tinsukia, Lakhimpur, Golaghat and Jorhat                             Orissa and Assam (Kamrup)                   Thailand
  7                  F          G        K        A        A       Chirang and Jorhat                                                                       Not found                                   Indonesia, Malaysia, Thailand and Kenya

*P. falciparum dhfr* and *dhps* two loci genotype among the field isolates of Chirang district of Assam showed that two patients had infections with triple *Pfdhfr* + triple *Pfdhps* mutant haplotypes which is known to be associated with high grade of SPR. Double mutant *Pfdhr + Pfdhps* was found only in 1.06% (1/94) of the field isolates, whereas triple *Pfdhr + Pfdhps* was found in 32.98% (31/94) and quadruple mutant *Pfdhr + Pfdhps* haplotype was detected among 60.64% (57/94) of *P. falciparum* field isolates in different malaria endemic areas of Assam. Rates of mutation differed from district to district. The presence of multiple mutations in the genes for both enzymes is an indication that resistance has reached an alarming level. These findings indicate that a high grade of SPR is seen in Assam and that the drug may not be a good choice to combine with artesunate. A recent study conducted by Sharma J *et al*. in 2014 revealed point mutations in *PfATPase6* gene among the isolates of Arunachal Pradesh, but without clinical correlation.\[[@ref23]\] Artemisinin combination (ACT (AS+SP) combination is being implemented by the Government of India in 67 districts of the North Eastern States. The high rate of SPR-associated mutations is a cause for concern and should be taken into account during policy planning. Regular molecular surveillance is required in the field for better management of malaria control through optimal use antimalarial drugs.
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